NexImmune
Stock Forecast, Prediction & Price Target
NexImmune Financial Estimates
NexImmune Revenue Estimates
NexImmune EBITDA Estimates
NexImmune Earnings per Share Estimates
Passed | Analyst forecast | ||||||
---|---|---|---|---|---|---|---|
Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | |
Revenue
% change YoY
| $0 N/A | $0 0% | $0 0% | Avg: $3.92B Low: $3.92B High: $3.92B avg. 0% | Avg: $0 Low: $0 High: $0 avg. -100% | Avg: $0 Low: $0 High: $0 avg. 0% | |
Net Income
% change YoY
| $-51.74M N/A | $514.18M 1093.67% | $-32.34M -106.29% | Avg: $-22.42M Low: $-1.11M High: $-1.11M avg. 30.65% | Avg: $-1.05M Low: $-1.05M High: $-1.05M avg. 95.27% | Avg: $-1.00M Low: $-1.00M High: $-1.00M avg. 4.95% | |
EBITDA
% change YoY
| $-52.39M N/A | $-62.50M -19.29% | $-28.16M 54.93% | Avg: $0 Low: $0 High: $0 avg. 100% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | |
EPS
% change YoY
| -$56.67 N/A | $534.29 1042.80% | -$30.82 -105.76% | Avg: -$1.06 Low: -$1.06 High: -$1.06 avg. 96.56% | Avg: -$1.01 Low: -$1.01 High: -$1.01 avg. 4.71% | Avg: -$0.96 Low: -$0.96 High: -$0.96 avg. 4.95% | |
Operating Expenses
% change YoY
| $53.25M N/A | $63.08M 18.45% | $28.16M -55.34% | Avg: $0 Low: $0 High: $0 avg. -100% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% |
FAQ
What is NexImmune stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 43.62% in 2025-2027.
We have gathered data from 1 analysts. Their low estimate is -1.11M, average is -22.42M and high is -1.11M.
What is NexImmune stock revenue growth forecast?
We have gathered data from 1 analysts. Their low revenue estimate is $3.92B, average is $3.92B and high is $3.92B.
What is NexImmune stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 35.40% in 2025-2027.
We have gathered data from 1 analysts. Their low earnings per share estimate is -$1.06, average is -$1.06 and high is $-1.06.